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Introduction
Laparoscopic surgery is an approved technique in 
colorectal cancer treatment. Lower rates of perioper-
ative complications and at least equal oncological re-
sults have been proven in randomised controlled tri-
als and confirmed with meta-analyses [1, 2]. Despite 
technical improvements to abdominoperineal resec-
tion [3], over the last two decades there has been 
a  significant shift in types of resections performed 
for rectal cancer treatment [4]. Improved surgical 
techniques and technology, introduction of neoadju-
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A b s t r a c t
Introduction: Laparoscopic surgery is an approved technique in colorectal cancer treatment. Functional and quali-
ty-of-life studies have revealed significant changes in faecal continence.
Aim: To assess the incidence and risk factors of low anterior resection syndrome (LARS) in patients undergoing rectal 
resections for cancer.
Material and methods: We enrolled patients undergoing rectal resections in a general surgery department of a uni-
versity hospital. The primary outcomes were the Jorge-Wexner scale and the LARS score 6 months after the end of 
treatment. The secondary outcomes were the risk factors for LARS development.
Results: Fifty-six patients were included; 15 (26%) developed major LARS and 10 (18%) had minor LARS at 6 months. 
In univariate analysis the risk factors were: preoperative radiotherapy (p < 0.001, OR = 11.9, 95% CI: 2.98–47.48); 
shorter distance of the tumour from the anal verge (p = 0.001, OR = 0.69, 95% CI: 0.55–0.86); bowel preparation 
(p = 0.01, OR = 6.27, 95% CI: 1.51–26.07); low anterior rectal resection (p = 0.01, OR = 17.07, 95% CI: 1.86–156.83); 
and protective ileostomy (p = 0.001, OR = 15.97, 95% CI: 4.07–61.92). The risk factors for a higher Jorge-Wexner 
score in univariate analysis were greater diameter of tumour (p = 0.035), radiotherapy (p = 0.001), shorter dis-
tance from the anal verge (p = 0.002), bowel preparation (p = 0.042), low anterior rectal (LAR) (p = 0.01), ileostomy 
(p = 0.001), perioperative complications (p = 0.032), and readmission within 30 days (p = 0.034). In the multivariate 
analysis, readmissions and perioperative complications were significant.
Conclusions: In addition to typically described risk factors, two new ones have been identified. Mechanical bowel 
preparation and defunctioning ileostomy may also contribute to LARS development. However, due to the limitations 
of this study our observations require further confirmation in future trials.
Key words: risk factors, rectal cancer, low anterior resection, low anterior resection syndrome, mechanical bowel 
preparation, ileostomy.
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vant treatment, and better understanding of disease 
biology have increased the proportions of patients 
undergoing sphincter-preserving procedures and 
decreased the percentage of abdominoperineal am-
putations [5]. At the same time, functional and qual-
ity-of-life assessment studies have brought to light 
significant changes in those domains resulting from 
the applied treatments [6]. Symptoms include, but are 
not limited to, difficulties with flatus and stool con-
trol, urgency to defecate, loss of sensory functions, 
emptying problems, and many others [7]. Prevalence 
of those symptoms amongst low anterior resection 
patients differs between the studies depending on 
definitions of low anterior resection syndrome (LARS) 
or its components and sensitivity of applied meas-
urement methodologies, but anything between 30% 
and 90% of patients may be involved. Different symp-
toms of low LARS have different effects on patients’ 
wellbeing. One of the most debilitating components 
of LARS is faecal incontinence. This influences many 
aspects of patient functioning, which is reflected in 
quality-of-life changes, mainly in coping and embar-
rassment domains [8]. Some speculation has been 
made on the exact aetiology of LARS. Disruption of 
somatic and/or autonomic innervations [9–11] and 
changes in rectal reservoir functions due to altera-
tions of rectal compliance or rectal ampulla volume 
have been suggested as possible causes [9, 12]. In 
addition, changes related to neoadjuvant treatment, 
probably mostly those attributed to radiotherapy, in-
fluence the functional results [13–15]. Loss of senso-
ry function of the recto-anal transitory zone is also 
thought to influence discriminatory function and en-
hance the probability of faecal incontinence [16].
There is little difference between open and lap-
aroscopic approaches in terms of rectal reservoir 
function, since this is dependent on anastomotic 
techniques and perhaps on the length of proximal 
resection, but there might be a difference in terms 
of preservation of neural structures. Key logic be-
hind this speculation would be better visualisation 
and precision of dissection resulting from operating 
field exposure and magnification. Conversely, due to 
lower degrees of freedom, lack of tactile assessment 
and increased technical difficulty, it may be the case 
that laparoscopy increases the probability of LARS 
[17]. To date most data have referred to patients op-
erated on with an open approach or mixed groups 
were analyzed. Moreover, perioperative protocols 
are leading to a  change of traditional risk factors 
for postoperative complications [18]. Whether they 
bring benefits beyond hospital stay is still under de-
bate. 
Aim
In this study we decided to establish risk factors 
for LARS in patients undergoing laparoscopic total 
mesorectal excision (TME) for rectal cancer.
Material and methods
Setting and design
Between 2014 and 2016, prospective data collec-
tion was performed in patients undergoing transab-
dominal resection for the treatment of rectal cancer. 
All procedures were performed in a tertiary-level uni-
versity teaching hospital. The annual volume of col-
orectal procedures exceeds 120, and approximately 
50 of those are performed for rectal cancer. Patients 
with histologically confirmed low and mid (< 10 cm 
from the anal verge) rectal adenocarcinoma were 
included in the study and were submitted to neo-
adjuvant chemoradiotherapy when indicated. Each 
patient underwent evaluation of faecal continence 
twice (before any treatment and 6 months after the 
end of treatment) or three times when undergoing 
neoadjuvant radiotherapy. We used the Jorge-Wex-
ner scale and LARS score for patient assessment: 
major LARS was defined as a LARS score > 30; mi-
nor LARS was defined as a LARS score of 21–29 [19, 
20]. Patients with any sort of faecal diversion at the 
time of the last evaluation (end colostomy, loop il-
eostomy) or those lost to follow-up were excluded 
from the study. All procedures were performed by 
the same surgical team, with the number of cases 
and conversion rates suggesting high placement on 
a  learning curve [21]. Assessment of complications 
was performed using the Clavien-Dindo Classifica-
tion, and we considered a  Clavien-Dindo score of 
III–V to be a severe complication [22]. Each patient 
was treated with the standardized Enhanced Recov-
ery after Surgery protocol with median compliance 
above 80% [23, 24].
Measured outcomes
The primary outcome was the LARS score and 
Jorge-Wexner score at 6 months after surgical treat-
ment [13, 20]. The secondary outcomes were the 
risk factors for LARS development.
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Operative technique
The surgical technique has been described else-
where as nerve preserving total mesorectal excision 
[25]. The anastomosis was performed using a  cir-
cumferential stapler. Protective ileostomy was cre-
ated for all anastomoses in the ultra-low anterior 
resection group and selectively in the low anterior 
resection group.
Statistical analysis
All data were analysed with Statistica version 
13.0 PL (StatSoft Inc., Tulsa, OK, USA). The results 
are presented as mean, standard deviation (SD), 
median, and interquartile range (IQR). The study of 
categorical variables used the c2 test of indepen-
dence. The Shapiro-Wilk test was used to check for 
normal distribution of data, and Student’s t test was 
used for normally distributed quantitative data. For 
non-normally distributed quantitative variables, the 
Mann-Whitney U  test was used. A  p-value < 0.05 
was considered statistically significant. All consider-
able patient- and treatment-related factors were an-
alysed in univariate logistic regression models, then 
significant factors were analysed in the multiple lo-
gistic regression model in search of independent risk 
factors for LARS.
The study was approved by the local ethics com-
mittee. Each patient signed an informed consent 
form before inclusion in the study.
Results
Eighty-three patients were eligible for the study. 
The group design is presented in Figure 1. Based on 
exclusion criteria, 56 patients were included in the 
study. Group characteristics and perioperative out-
comes are shown in Table I.
Fifteen (26%) patients developed major LARS 
and 10 (18%) patients had symptoms of minor LARS 
6 months after surgery. The risk factors of LARS 
in univariate analysis were as follows: preopera-
tive radiotherapy (OR = 11.9, 95% CI: 2.98–47.48, 
p < 0.001); bowel preparation (OR = 6.27, 95% CI: 
1.51–26.07, p = 0.01); ultra-low anterior rectal re-
section (OR = 17.07, 95% CI: 1.86–156.83, p = 0.01); 
and protective ileostomy creation (OR = 15.97, 
95% CI: 4.07–61.92, p = 0.001). Greater distance 
of the tumour from the anal verge reduced the in-
cidence of LARS (OR = 0.69, 95% CI: 0.55–0.86, 
p = 0.001). When multivariate analysis was performed, 
none of the analyzed factors turned out to be a major 
factor contributing to LARS development. A summary 
of our results is included in Tables II and III.
The median Jorge-Wexner score after surgery 
was 3 points (IQR: 0–8, range: 0–18). The risk fac-
tors for a  higher Jorge-Wexner score in univariate 
analysis were a  higher T parameter in the TNM 
classification (p = 0.035), radiotherapy (p = 0.001), 
shorter distance of the tumour from the anal verge 
(p = 0.002), bowel preparation (p = 0.042), low an-
terior rectal resection (p = 0.01), ileostomy creation 
(p = 0.001), perioperative complications (p = 0.032) 
and readmission to the hospital within 30 days 
(p = 0.034). In multivariate analysis, readmissions 
and perioperative complications were a  risk fac-
tors of a higher Jorge-Wexner score (p = 0.021 and 
p = 0.04, respectively).
Eighteen patients suffered from postoperative com-
plications, including five considered severe (Clavien- 
Dindo III–V): three presented anastomotic leakage 
and two postoperative ileus. There were four 30-day 
readmissions due to late postoperative complica-
tions, none of which required surgical intervention. 
There were no mortalities within 30 days of the sur-
gical procedure.
Discussion
In our study we demonstrated that a laparoscop-
ic approach is a safe and valuable tool for rectal re-
sections in treatment of rectal cancer. However, 44% 
of patients developed minor or major LARS, which 
remains a high incidence rate. 
Protective ileostomy was found to be a risk fac-
tor for LARS development after rectal resection, con-
firmed both in the LARS score and the Jorge-Wexner 
scale. This fact is rarely reported in the literature. 
Similar findings were presented by Jimenez-Gomez Figure 1. Study group design
83 patients eligible for the study
67 patients completed follow-up
56 patients included to the study
16 patients lost in follow-up
11 patients still have ileostomy  
or end colostomy
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et al. [26]. Moreover, data from the LAARIS Trial Man-
agement Group indicate that a longer time from the 
initial procedure to ileostomy reversal increases LARS 
incidence [27]. That finding was not confirmed in the 
above-mentioned study by Jimènez-Rodriguez et al. 
[28]. Ileostomy creation decreases the rate of anasto-
motic leakage after rectal resections, although it may 
also increase the overall complication rate [29]. There-
fore, the decision of ileostomy creation is even more 
challenging. Seeing that the literature data is incon-
sistent, further research in this field is needed. To date 
it seems that if ileostomy is performed it should be 
reversed within 6 months, since the LARS incidence 
in that case may be lower [27]. Moreover, there is ev-
idence that very early ileostomy closure is beneficial 
and does not influence adjuvant treatment [30–32].
A novel finding in our study is that mechanical 
bowel preparation (MBP) is associated with increased 
risk of LARS. Although it was said that patients do 
not benefit from bowel preparation [33, 34], recently 
this opinion has been challenged again. Some new 
studies have shown that MBP combined with anti-
biotic preparation efficiently reduces perioperative 
complications in colorectal surgery [35–38]. These 
studies are, however, prone to selection bias – pa-
tients in the no-MBP group were characterized by 
a higher comorbidity rate, more advanced stage of 
cancer, higher rate of renal and liver failure as well 
as more frequent steroid use. In addition, the most 
recent analysis based on the same registry data as 
previous analyses with propensity score matching 
confirmed that it is oral antibiotics rather than MBP 
Parameter Results
Males/females 28/28 (50%/50%)
Age, mean ± SD, min.–max. [years] 61 ±11, 36–83
BMI, median (IQR); min.–max. [kg/m2] 26.58 (24.04–29.71); 
19.00–43.51
ASA 1, n (%) 2 (3.57)
ASA 2, n (%) 50 (89.29)
ASA 3, n (%) 4 (7.14)
Any significant comorbidity, n (%) 32 (57.14)
Diabetes mellitus, n (%) 11 (19.64)
Arterial hypertension, n (%) 22 (39.29)
Coronary artery disease, n (%) 15 (26.79)
Renal comorbidity, n (%) 2 (3.57)
Hepatic comorbidity, n (%) 1 (1.79)
Pulmonary comorbidity, n (%) 1 (1.79)
T 0 3 (6%)
1 2 (4%)
2 10 (20%)
3 31 (62%)
4 4 (8%)
N 0 34 (70.83%)
1 6 (12.5%)
2 8 (16.67%)
AJCC 0 2 (3.57%)
1 19 (33.93%)
2 20 (35.71%)
3 15 (26.79%)
Parameter Results
Radiotherapy 23 (46.94%)
Depth, median (IQR) [cm] 10 (7–12)
Depth 1 24 (42.86%)
2 23 (41.07%)
3 9 (16.07%)
Bowel preparation 37 (66.07%)
Pre-op. drink 48 (85.71%)
Locoregional anaesthesia 27 (58.70%)
Laparoscopic low anterior resection 47 (83.93%)
Laparoscopic ultra-low anterior 
resection
9 (16.07%)
Ileostomy 22 (39.29%)
Operative time, median (IQR) [min] 195 (140–240)
Blood loss, median (IQR) [ml] 70 (50–150)
Perioperative complications 18 (32.14%)
Clavien- 
Dindo 
classifi-
cation
I 11 (19.64%)
II 2 (3.57%)
III 5 (8.93%)
LOS, median (IQR) [days] 5 (3–7)
Readmissions 4 (8.33%)
Postoperative Wexner, median (IQR) 3 (0.5–8)
Minor LARS 8 (14.29%)
Major LARS 15 (26.79%)
Table I. General characteristics and perioperative outcomes
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Table II. Factors influencing odds ratio for LARS
Parameter OR 95% CI P-value
Univariate:
Males vs. females 2.11 0.70–6.41 0.177
Age 0.98 0.93–1.03 0.364
BMI 0.95 0.84–1.08 0.448
ASA 0.55 0.09–3.22 0.499
Comorbidity 0.71 0.24–2.13 0.531
Diabetes mellitus 0.25 0.05–1.36 0.102
Arterial hypertension 1.35 0.44–4.09 0.592
Coronary artery disease 0.42 0.11–1.59 0.192
Renal comorbidity n/a
Hepatic comorbidity 2.07 0.001–9.99 0.999
Pulmonary comorbidity n/a
T 0.60 0.30–1.18 0.131
N 0.91 0.42–1.98 0.812
AJCC 0.93 0.49–1.76 0.820
Radiotherapy 11.9 2.98–47.48 < 0.001
Depth 0.69 0.55–0.86 0.001
Bowel preparation 6.27 1.51–26.07 0.010
Pre-op. drink 1.19 0.25–5.77 0.825
Locoregional anaesthesia 1.48 0.44–5.00 0.515
Laparoscopic ultra-low  
anterior resection vs. laparo-
scopic low-anterior resection
17.07 1.86–156.83 0.010
Vessels 2 vs. 1 1.12 0.34–3.73 0.852
Ileostomy 15.87 4.07–61.92 < 0.001
Operative time 0.99 0.98–1.01 0.671
Blood loss 0.99 0.98–1.00 0.127
Perioperative complications 1.71 0.54–5.47 0.352
Clavien-Dindo 2.33 0.34–15.83 0.378
LOS 1.12 0.98–1.28 0.076
Readmissions 4.33 0.39–48.00 0.220
Multivariate:
Radiotherapy 2.60 0.28–24.05 0.388
Depth 1.89 0.51–7.03 0.330
Bowel preparation 2.40 0.28–20.84 0.413
Laparoscopic ultra-low anterior 
resection vs. laparoscopic low 
anterior resection
3.27 0.27–39.69 0.339
Ileostomy 1.80 0.14–23.80 0.648
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Table III. Regression models of parameters influencing postoperative Wexner score
Parameter Parameter ± SD P-value
Univariate:
Males vs. females –0.43 ±0.82 0.602
Age –0.001 ±0.074 0.986
BMI –0.343 ±0.171 0.050
ASA –1.048 ±2.514 0.678
Comorbidity –0.198 ±0.827 0.812
Diabetes mellitus –1.170 ±1.019 0.256
Arterial hypertension 0.398 ±0.837 0.636
Coronary artery disease –1.189 ±0.911 0.197
Renal comorbidity –0.833 ±2.204 0.707
Hepatic comorbidity –1.836 ±3.083 0.554
Pulmonary comorbidity –0.309 ±3.093 0.921
T 1.747 ±0.803 0.035
N –0.060 ±1.040 0.954
AJCC –0.199 ±0.959 0.836
Radiotherapy 3.019 ±0.816 0.001
Depth –0.823 ±0.203 0.002
Bowel preparation 1.734 ±0.832 0.042
Pre-op. drink –0.448 ±1.169 0.703
Locoregional anaesthesia –0.640 ±0.897 0.479
Laparoscopic ultra-low anterior resection 
vs. laparoscopic low-anterior resection
2.816 ±1.047 0.010
Vessels 2 vs. 1 0.962 ±0.908 0.295
Ileostomy 2.757 ±0.750 0.001
Operative time 0.009 ±0.013 0.486
Blood loss –0.008 ±0.006 0.233
Perioperative complications 1.845 ±0.840 0.032
3 vs. 2-1 Clavien-Dindo 1.204 ±1.427 0.403
Clavien-Dindo 1.289 ±0.868 0.143
LOS 0.211 ±0.163 0.201
Readmissions 3.523 ±1.615 0.034
Multivariate:
Constant term 10.105 ±5.933 0.099
T –1.212 ±0.942 0.208
Radiotherapy 4.459 ±2.878 0.132
Depth –0.393 ±0.335 0.250
Laparoscopic ultra-low anterior resection 
vs. laparoscopic low-anterior resection
1.379 ±2.346 0.561
Ileostomy –2.087 ±3.402 0.544
Perioperative complications 3.578 ±1.669 0.040
Readmissions 6.696 ±2.902 0.028
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that reduced complication rates [39]. Therefore if 
MBP seems to be ineffective and also may contrib-
ute to LARS development the decision to perform 
MBP should be carefully considered and well justi-
fied. Mechanical bowel preparation may be neces-
sary when defunctioning ileostomy or transanal TME 
is planned; nonetheless van’t Sant et al. questioned 
that hypothesis in a  large multicenter study [40]. 
Also Pittet et al. suggested that rectal enema may 
successfully replace MBP [41]. Bearing in mind our 
results the decision of MBP is still uncertain and re-
quires extensive investigation.
Perioperative radiotherapy is a risk factor of fae-
cal incontinence 6 months after the surgery. Other 
authors also identified neoadjuvant radiotherapy 
as a factor leading to LARS [26, 42, 43]. Postopera-
tive radiotherapy also causes deterioration of anal 
sphincter function [44, 45]. The effect of radiothera-
py is not only clinically significant, but also is visible 
in manometric studies [46]. Nevertheless, radiother-
apy significantly improves overall survival and dis-
ease-free survival, and thus the elimination of this 
part of modern treatment is not possible [47, 48]. 
However, more cautious selection of patients for pre-
operative radiotherapy should be performed in order 
to limit anal sphincter dysfunction.
A shorter distance from the anal verge and a larg-
er size of the tumour are associated with LARS in the 
postoperative period. This is probably caused by the 
necessity of more extensive surgical techniques in 
order to gain proper resection margins. The type of 
the procedure (partial mesorectal excision vs. total 
mesorectal excision) is also considered as a risk fac-
tor of LARS [49].
Laparoscopic technique resulted in a  lower LARS 
score according to Nuytens et al. [42]. In contrast, 
a meta-analysis performed by Lim et al. showed no 
difference between minimally invasive and open ap-
proaches regarding sexual and bladder functions [50]. 
There are few published studies comparing laparo-
scopic and open approaches in assessing long-term 
functional outcomes regarding anal sphincters. We 
had no open cases or conversions in our material, so 
such an analysis was impossible. Nevertheless the in-
cidence of LARS in our material is comparable to other 
authors who use an open approach [49]. This suggests 
no superiority of minimally invasive techniques, but 
further investigations including RCTs are necessary.
Anastomosis with mechanical staplers reduces 
the incidence of LARS [43]. In our study, all anasto-
moses were performed using a mechanical stapler, 
so we cannot draw any conclusions regarding that 
variable. 
Our study has some limitations, amongst which 
the relatively small number of included patients may 
result in a type II error. Moreover, we did not perform 
an analysis between LARS and time to ileostomy clo-
sure. Lastly, although some risk factors have been 
identified, they were not confirmed in the multivari-
ate model, which is likely due to the limited number 
of cases or number of influencing variables leading 
to study group heterogeneity. Therefore, larger trials 
are needed in order to confirm our findings. 
Conclusions
In this study we were able to confirm that tradi-
tional risk factors for LARS are also present in laparo-
scopic rectal surgery. In addition, two new potential 
risk factors have been identified. Mechanical bowel 
preparation, being a part of perioperative care in rec-
tal surgery, has been suggested to contribute to LARS 
development. In addition, defunctioning ileostomy 
may also have an impact on impaired function of the 
neorectum in the early postoperative period. Howev-
er, due to the limitations of this study our observa-
tions require further confirmation in future trials. 
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